Bioventus Inc
NASDAQ:BVS
Bioventus Inc
Operating Income
Bioventus Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Bioventus Inc
NASDAQ:BVS
|
Operating Income
-$55m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cooper Companies Inc
NYSE:COO
|
Operating Income
$536.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Operating Income
$296m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Operating Income
$663.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Operating Income
$374.1m
|
CAGR 3-Years
165%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is Bioventus Inc's Operating Income?
Operating Income
-55m
USD
Based on the financial report for Dec 31, 2022, Bioventus Inc's Operating Income amounts to -55m USD.